https://prometrapump.com/
Prometrapump.com – Precision-dosed implantable drug delivery system
drug deliveryprecisiondosedimplantablesystem
https://infusyn.com/
Infusyn – Realizing the promise of precisely dosed therapeutics
Setting a New Standard in Precision Dosing The Prometra® II Drug Delivery System brings new levels of accuracy and precision to drug delivery to help treat...
the promiserealizingpreciselydosedtherapeutics
https://www.businesswire.com/news/home/20221108005986/en/Beckley-Psytech-Announces-First-Participant-Dosed-in-Phase-I-Trial-of-ELE-101-A-Novel-Intravenous-Formulation-of-Psilocin
Beckley Psytech Announces First Participant Dosed in Phase I Trial of ELE-101, A Novel Intravenous...
Beckley Psytech, a clinical-stage biotechnology company dedicated to addressing neuropsychiatric conditions through the novel application of psychedelic medi...
https://pubchem.ncbi.nlm.nih.gov/bioassay/1425366
AID 1425366 - Acute toxicity in Beagle dog assessed as weight gain at 0.625 to 20 mg/kg, iv dosed...
BioAssay record AID 1425366 submitted by ChEMBL: Acute toxicity in Beagle dog assessed as weight gain at 0.625 to 20 mg/kg, iv dosed with 48 to 96 hrs between...
https://www.businesswire.com/news/home/20260413254076/en/Enanta-Pharmaceuticals-Announces-First-Participant-Dosed-in-Phase-1-Clinical-Trial-of-EDP-978-an-Oral-Once-Daily-KIT-Inhibitor-in-Development-for-the-Treatment-of-Urticaria
Enanta Pharmaceuticals Announces First Participant Dosed in Phase 1 Clinical Trial of EDP-978, an...
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immuno...
https://pubchem.ncbi.nlm.nih.gov/bioassay/1263458
AID 1263458 - Antipsychotic activity in po dosed mouse assessed as reversal of MK-801-induced...
BioAssay record AID 1263458 submitted by ChEMBL: Antipsychotic activity in po dosed mouse assessed as reversal of MK-801-induced hyperactivity.
https://pubchem.ncbi.nlm.nih.gov/bioassay/1621352
AID 1621352 - Dose normalized AUC in LYD pig at 1.6 mM, sc co-dosed with 1.6 mM liraglutide by...
BioAssay record AID 1621352 submitted by ChEMBL: Dose normalized AUC in LYD pig at 1.6 mM, sc co-dosed with 1.6 mM liraglutide by LC-MS analysis.
https://offsettingbehaviour.blogspot.com/2021/08/dosed.html?m=0
Offsetting Behaviour: Dosed
Driving home from Palmerston North last night around 6pm, a man was waiving a Covid-19 Vaccination Centre banner on the median of the road o...
offsettingbehaviourdosed
https://dosedmovie.com/
Home - DOSED Movies
Dec 22, 2025 - Focused on healing from within - Golden Teacher Films is offering the DOSED collection: two award-winning documentaries, two bonus-feature videos, and an...
dosedmovies
https://www.globenewswire.com/news-release/2024/05/01/2873595/0/en/Galecto-Announces-First-Patient-Dosed-in-an-Investigator-Initiated-Phase-2-Trial-of-GB1211-in-Combination-with-Pembrolizumab.html
Galecto Announces First Patient Dosed in an
An NCI-supported Phase 2 investigator-initiated trial at the Providence Cancer Institute in Portland, Oregon, has enrolled its first patient in a study...
first patientannouncesdosed
https://www.businesswire.com/news/home/20260209315923/en/VectorY-Therapeutics-Announces-First-Participant-Dosed-in-Phase-12-PIONEER-ALS-Clinical-Trial-of-VTx-002-in-People-with-Amyotrophic-Lateral-Sclerosis-ALS?dm_i=40VQ,1RZ6S,73ZN21,710VW,1,0,0,0
VectorY Therapeutics Announces First Participant Dosed in Phase 1/2 PIONEER-ALS Clinical Trial of...
VectorY Therapeutics, a leader in vectorized antibody therapies for neurodegenerative diseases, announced today that the first participant has been dosed in ...
https://www.prnewswire.com/news-releases/phosplatin-therapeutics-announces-first-patient-dosed-in-phase-2-clinical-trial-of-pt-112-for-thymoma-and-thymic-carcinoma-in-collaboration-with-national-cancer-institute-301524327.html
Phosplatin Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of PT-112 for...
/PRNewswire/ -- Phosplatin Therapeutics Inc., a clinical stage pharmaceutical company focused on oncology therapeutics, today announced the first patient has...
https://thelongevityedge.com/
Clinically Dosed Longevity Supplements | The Longevity Edge
Jun 21, 2026 - Clinically dosed supplements at the amounts published studies actually used. Transparent labels, plain claims. Formulated by Dr. David Woynarowski, MD.
longevity supplementsdosededge
https://www.prnewswire.com/news-releases/mahzi-therapeutics-announces-first-patient-dosed-in-phase-12-unite-study-of-mz-1866-for-pitt-hopkins-syndrome-302696349.html?tc=eml_cleartime&blm_aid=0
Mahzi Therapeutics Announces First Patient Dosed in Phase 1/2 UNITE Study of MZ-1866 for Pitt...
/PRNewswire/ -- Mahzi Therapeutics Inc., a clinical-stage biotechnology company developing precision therapies for neurogenetic disorders, today announced...
https://www.businesswire.com/news/home/20240429438564/en/Inflammasome-Therapeutics-Announces-First-Patient-Dosed-in-Geographic-Atrophy-GA-Clinical-Trial
Inflammasome Therapeutics Announces First Patient Dosed in Geographic Atrophy (GA) Clinical Trial
Inflammasome Therapeutics (https://www.inflam.com), a private company developing a new class of inflammasome inhibitor drugs, Kamuvudines, as therapies for p...
first patient
https://pubchem.ncbi.nlm.nih.gov/bioassay/1270623
AID 1270623 - Elimination half life in po dosed patient plasma by HPLC/MS analysis - PubChem
BioAssay record AID 1270623 submitted by ChEMBL: Elimination half life in po dosed patient plasma by HPLC/MS analysis.
https://www.cbsnews.com/news/jade-janks-tom-merriman-murder-plot-revealed-in-california-womans-text-messages/
Murder plot revealed in Jade Janks' text messages: "I just dosed the hell out of him" - CBS News
A woman discovers explicit photos of herself on her stepfather's computer. Soon after, he's found dead. Evidence points to an overdose, but was it murder?
https://www.businesswire.com/news/home/20231115320093/en/Orionis-Biosciences-Announces-First-Patient-Dosed-in-Phase-1-Clinical-Trial-of-ORB-011-in-Patients-with-Advanced-Solid-Tumors
Orionis Biosciences Announces First Patient Dosed in Phase 1 Clinical Trial of ORB-011 in Patients...
Orionis Biosciences, a life sciences company pioneering the creation of highly selective and tunable therapeutics for cancer and other diseases, today announ...
https://pubchem.ncbi.nlm.nih.gov/bioassay/1099499
AID 1099499 - Acute toxicity in po dosed Mus musculus ICR (mouse) assessed as mortality measured...
BioAssay record AID 1099499 submitted by ChEMBL: Acute toxicity in po dosed Mus musculus ICR (mouse) assessed as mortality measured after 14 days.
https://pubchem.ncbi.nlm.nih.gov/bioassay/1096383
AID 1096383 - Neurotoxicity in ip dosed Mus musculus (mouse) assessed as minimal motor impairment...
BioAssay record AID 1096383 submitted by ChEMBL: Neurotoxicity in ip dosed Mus musculus (mouse) assessed as minimal motor impairment after 4 hr by rotarod test.
https://www.prnewswire.com/news-releases/accent-therapeutics-announces-first-patient-dosed-in-phase-12-trial-of-atx-559-and-chief-scientific-officer-transition-302328238.html
Accent Therapeutics Announces First Patient Dosed in Phase 1/2 Trial of ATX-559 and Chief...
/PRNewswire/ -- Accent Therapeutics, a clinical-stage biopharmaceutical company pioneering novel, targeted, small molecule cancer therapeutics, today...
https://pubchem.ncbi.nlm.nih.gov/bioassay/1083368
AID 1083368 - Neurotoxicity in ip dosed Mus musculus albino (mouse) after 4 hr rotorod test -...
BioAssay record AID 1083368 submitted by ChEMBL: Neurotoxicity in ip dosed Mus musculus albino (mouse) after 4 hr rotorod test.
https://www.businesswire.com/news/home/20240201668709/en/RS-Oncology-Announces-First-Patient-Dosed-in-Phase-2-Clinical-Study-MITOPE-Investigating-RSO-021-for-the-Treatment-of-Malignant-Pleural-Mesothelioma-and-Metastatic-Disease-to-the-Lung
RS Oncology Announces First Patient Dosed in Phase 2 Clinical Study (MITOPE) Investigating RSO-021...
A first-in-kind therapy for pleural mesothelioma and metastatic disease to the lungs expanded into phase 2 of the UK investigational study.
https://nakedemperor.substack.com/p/two-dosed-18-39-year-olds-are-4-times?s=w
Two dosed 18-39 year olds are 4 times more likely to die from non-Covid causes.
Deaths by vaccination status in England
https://www.businesswire.com/news/home/20201006005263/en/Cerevel-Therapeutics-Announces-First-Patient-Dosed-in-Phase-2-Trial-of-CVL-865-an-Investigational-Therapy-in-Development-for-the-Treatment-of-Epilepsy
Cerevel Therapeutics Announces First Patient Dosed in Phase 2 Trial of CVL-865, an Investigational...
Cerevel Therapeutics, a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, today announced dose administration for th...
https://www.globenewswire.com/news-release/2025/06/12/3098051/0/en/SNIPR-BIOME-Announces-First-Patient-Dosed-in-its-Phase-1b-Clinical-Trial-of-SNIPR001-in-Patients-with-Hematological-Cancer.html
SNIPR BIOME Announces First Patient Dosed in its Phase 1b
SNIPR BIOME today announced that the first patient has been dosed in its Phase 1b study of SNIPR001 in patients with hematological cancer....
first patientsniprbiomeannouncesdosed
https://perfectlydosed.com/
Perfectly Dosed
We do the science so you don
perfectlydosed
https://xjtsprayer.en.made-in-china.com/product/fOqTjWIUHSax/China-20mm-Crimp-on-Nasal-Spray-100mcl-Metered-Dosed-Nasal-Sprayer.html
20mm Crimp on Nasal Spray 100mcl Metered Dosed Nasal Sprayer - Nasal Spray Bottle and Nasal Spray
20mm Crimp on Nasal Spray 100mcl Metered Dosed Nasal Sprayer, Find Details and Price about Nasal Spray Bottle Nasal Spray from 20mm Crimp on Nasal Spray 100mcl...
nasal spraysprayer bottlecrimp
https://pubchem.ncbi.nlm.nih.gov/bioassay/1095254
AID 1095254 - Neurotoxicity in ip dosed Mus musculus Kunming (mouse) assessed as minimal motor...
BioAssay record AID 1095254 submitted by ChEMBL: Neurotoxicity in ip dosed Mus musculus Kunming (mouse) assessed as minimal motor impairment at 0.5 hr by...
https://pubchem.ncbi.nlm.nih.gov/bioassay/1083695
AID 1083695 - Neurotoxicity in ip dosed Mus musculus C57B/6 (mouse) assessed motor impairment after...
BioAssay record AID 1083695 submitted by ChEMBL: Neurotoxicity in ip dosed Mus musculus C57B/6 (mouse) assessed motor impairment after 0.5 hr by rotarod test.
https://pubchem.ncbi.nlm.nih.gov/bioassay/1115592
AID 1115592 - Neurotoxicity in i.p. dosed Swiss albino Mus musculus (mouse) assessed as spontaneous...
BioAssay record AID 1115592 submitted by ChEMBL: Neurotoxicity in i.p. dosed Swiss albino Mus musculus (mouse) assessed as spontaneous PNS effects after...
https://markets.businessinsider.com/news/stocks/perspective-therapeutics-announces-first-patient-dosed-with-212pb-vmt01-monotherapy-at-1-5-mci-in-a-phase-1-2a-study-of-mc1r-positive-metastatic-melanoma-1034573526
Perspective Therapeutics Announces First Patient Dosed with [212Pb]VMT01 Monotherapy at 1.5 mCi in...
SEATTLE, April 11, 2025 (GLOBE NEWSWIRE) -- Perspective, Therapeutics, Inc. ('Perspective' or the 'Company') (NYSE AMERICAN: CATX), a radiophar...
https://www.prnewswire.com/news-releases/first-patient-dosed-in-nefigard-open-label-extension-study-301221986.html
First Patient Dosed in NefIgArd Open Label Extension Study
/PRNewswire/ -- Calliditas Therapeutics AB (publ) ("Calliditas") today announced that the first patient has been dosed in the global open-label extension...
first patientdosedopenlabelextension
https://www.businesswire.com/news/home/20250717737583/en/MOMA-Therapeutics-Announces-First-Patient-Dosed-in-Phase-1-Clinical-Trial-for-MOMA-341-a-Highly-Potent-and-Selective-Werner-Helicase-Inhibitor
MOMA Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial for MOMA-341, a Highly...
MOMA Therapeutics, a clinical-stage biopharmaceutical company discovering and developing a new generation of precision therapeutics, today announced that the...
https://fr.mathworks.com/help/simbio/ref/dosed.html
Dosed - Dosed object name - MATLAB
Dosed is a property of the PKModelMap object.
dosedobjectnamematlab
https://www.businesswire.com/news/home/20211018005226/en/Vertex-Announces-Positive-Day-90-Data-for-the-First-Patient-in-the-Phase-12-Clinical-Trial-Dosed-With-VX-880-a-Novel-Investigational-Stem-Cell-Derived-Therapy-for-the-Treatment-of-Type-1-Diabetes
Vertex Announces Positive Day 90 Data for the First Patient in the Phase 1/2 Clinical Trial Dosed...
Vertex today announced positive data for the first patient from the Phase 1/2 clinical trial of VX-880, for the treatment of type-1 diabetes.
https://pubchem.ncbi.nlm.nih.gov/bioassay/1425432
AID 1425432 - Chronic toxicity in po dosed male rat assessed as no observable adverse effect level...
BioAssay record AID 1425432 submitted by ChEMBL: Chronic toxicity in po dosed male rat assessed as no observable adverse effect level administered daily for 28...
https://pubchem.ncbi.nlm.nih.gov/bioassay/1619598
AID 1619598 - Clearance in iv dosed mouse - PubChem
BioAssay record AID 1619598 submitted by ChEMBL: Clearance in iv dosed mouse.
aidclearanceivdosedmouse
https://www.prnewswire.com/news-releases/gentibio-announces-first-participant-dosed-in-polaris-phase-1-clinical-trial-of-gnti-122-in-recently-diagnosed-type-1-diabetes-302716586.html
GentiBio Announces First Participant Dosed in POLARIS Phase 1 Clinical Trial of GNTI-122 in...
/PRNewswire/ -- GentiBio, Inc., a clinical-stage biotechnology company pioneering engineered, antigen-specific regulatory T cell (EngTreg) therapies, today...
https://www.livescience.com/65788-world-war-ii-nazis-methamphetamines.html
Nazis Dosed Soldiers with Performance-Boosting 'Superdrug' | Live Science
Jun 25, 2019 - The remarkable endurance of German and Allied soldiers during World War II had a secret ingredient.
performance boostingnazisdosedsoldierssuperdrug
https://www.prnewswire.com/news-releases/first-patient-dosed-in-phase-ii-ipax-linz-study-of-tlx101-for-glioblastoma-therapy-301684358.html
First Patient Dosed in Phase II 'IPAX-Linz' Study of TLX101 for Glioblastoma Therapy
/PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that a first patient has been dosed in a Phase II...
https://proteomicsnews.blogspot.com/2023/11/deep-quantitative-proteomics-of-human.html
News in Proteomics Research: Deep quantitative proteomics of human brain cells in culture dosed...
And...now for something completely different and suprising! (honestly thought I'd posted this a couple weeks ago). Immortalized human neu...
news in
https://www.prweb.com/releases/statewide_collective_now_offering_consistent_dosed_cannabis_products/prweb12488816.htm
StateWide Collective Now Offering Consistent Dosed Cannabis Products
Santa Monica, California (PRWEB) February 04, 2015 -- Although when most people think of medical cannabis, they think of smokable products and edibles, there...
now offeringstatewidecollectiveconsistentdosed
https://pubchem.ncbi.nlm.nih.gov/bioassay/1096388
AID 1096388 - Anticonvulsant activity in ip dosed Mus musculus (mouse) assessed as protection...
BioAssay record AID 1096388 submitted by ChEMBL: Anticonvulsant activity in ip dosed Mus musculus (mouse) assessed as protection against subcutaneous pentylene...
https://www.businesswire.com/news/home/20230124005493/en/Vistagen-Announces-First-Participants-Dosed-in-Phase-1-Clinical-Trial-of-PH10-an-Investigational-Pherine-Nasal-Spray-for-Major-Depressive-Disorder
Vistagen Announces First Participants Dosed in Phase 1 Clinical Trial of PH10, an Investigational...
Vistagen (NASDAQ: VTGN) a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depr...
https://pubchem.ncbi.nlm.nih.gov/bioassay/1083689
AID 1083689 - Anticonvulsant activity in ip dosed Mus musculus C57B/6 (mouse) assessed protection...
BioAssay record AID 1083689 submitted by ChEMBL: Anticonvulsant activity in ip dosed Mus musculus C57B/6 (mouse) assessed protection against 6 Hz psychomotor...
https://amandageorgeuk.blogspot.com/2021/11/thats-me-dosed-up-until-this-evening.html
Amanda's blog: That's me dosed up until this evening
blog, blogger, to-do list, comment, photo, rant, health, illness, disability, frustration
amanda sblogdosedevening
https://pubchem.ncbi.nlm.nih.gov/bioassay/1339722
AID 1339722 - Inhibition of atrial fibrillation in iv dosed Mongrel dog vagal-atrial fibrillation...
BioAssay record AID 1339722 submitted by ChEMBL: Inhibition of atrial fibrillation in iv dosed Mongrel dog vagal-atrial fibrillation model assessed as median...
atrial fibrillation
https://www.globenewswire.com/de/news-release/2023/04/26/2655181/0/en/ContraFect-Announces-First-Patient-Dosed-in-the-Phase-1b-2-Study-of-Exebacase-in-Patients-with-Chronic-Prosthetic-Joint-Infections-of-the-Knee.html
ContraFect Announces First Patient Dosed in the Phase 1b/2
YONKERS, N.Y., April 26, 2023 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology company focused on the discovery...
first patientin theannouncesdosedphase
https://portal.fis.tum.de/en/publications/stromungsverhalten-bei-rondo-ringwirbelvernebelung-zur-optimierte/
Flow behaviour with 'Rondo' annular vortex atomization for an optimized dosed-aerosol inhaling -...
https://www.businesswire.com/news/home/20240827634169/en/Axalbion-Therapeutics-Announces-First-Patient-Dosed-in-Phase-2-Clinical-Study-in-Chronic-Cough-with-AX-8-a-Novel-TRPM8-Agonist
Axalbion Therapeutics Announces First Patient Dosed in Phase 2 Clinical Study in Chronic Cough with...
Axalbion, a clinical-stage biopharmaceutical company focused on developing novel medicines to treat cough, announced that the first patient has been dosed in...